Security key
74365A309
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)
CUSIP: 74365A309
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 80,361,978
- Total 13F shares
- 8,974,519
- Share change
- +6,036,881
- Total reported value
- $17,902,094
- Put/Call ratio
- 19%
- Price per share
- $2.00
- Number of holders
- 66
- Value change
- +$11,998,091
- Number of buys
- 54
- Number of sells
- 13
Report period
Q2 2023
Institutions
66
Top holders
10
PLX full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Protalix BioTherapeutics, Inc. SEC filings
Protalix BioTherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74365A309
Recent filing periods:
Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
1,209,750
|
$2,540,000 | — | 31 Mar 2023 | |
| MEITAV INVESTMENT HOUSE LTD |
13F
|
Company |
0.3%
|
244,332
|
$493,551 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
211,548
|
$444,251 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
194,094
|
$407,597 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.2%
|
158,703
|
$333,276 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.19%
|
150,358
|
$315,753 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
133,790
|
$280,959 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.14%
|
116,143
|
$243,900 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
86,698
|
$182,000 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
82,176
|
$172,570 | — | 31 Mar 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.06%
|
50,100
|
$105,000 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
39,665
|
$83,296 | — | 31 Mar 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
34,064
|
$71,534 | — | 31 Mar 2023 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0.03%
|
26,800
|
$56,280 | — | 31 Mar 2023 | |
| EARNED WEALTH ADVISORS, LLC |
13F
|
Company |
0.03%
|
25,974
|
$54,545 | — | 31 Mar 2023 | |
| CIBC WORLD MARKET INC. |
13F
|
Company |
0.03%
|
25,000
|
$52,000 | — | 31 Mar 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.03%
|
20,760
|
$43,596 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
19,900
|
$41,790 | — | 31 Mar 2023 | |
| Sculptor Capital LP |
13F
|
Company |
0.02%
|
19,100
|
$40,110 | — | 31 Mar 2023 | |
| Aptus Capital Advisors, LLC |
13F
|
Company |
0.02%
|
16,010
|
$33,621 | — | 31 Mar 2023 | |
| Lido Advisors, LLC |
13F
|
Company |
0.02%
|
15,554
|
$32,663 | — | 31 Mar 2023 | |
| Altshuler Shaham Ltd |
13F
|
Company |
0.02%
|
12,142
|
$25,498 | — | 31 Mar 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
10,309
|
$21,000 | — | 31 Mar 2023 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
6,100
|
$12,749 | — | 31 Mar 2023 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.01%
|
6,000
|
$13,200 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
5,761
|
$12,098 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,691
|
$9,851 | — | 31 Mar 2023 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
3,880
|
$8,148 | — | 31 Mar 2023 | |
| Psagot Value Holdings Ltd. / (Israel) |
13F
|
Company |
0%
|
3,744
|
$7,000 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2,000
|
$4,200 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,602
|
$3,000 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
601
|
$1,262 | — | 31 Mar 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
250
|
$525 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
39
|
$82 | — | 31 Mar 2023 | |
| Dexcel Pharma Technologies Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,637,314
|
$5,128,613 | — | 02 Jun 2021 | |
| Zeev Bronfeld |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 07 Sep 2022 |
Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q2 2023
As of 30 Jun 2023,
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,974,519 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, NATIONAL BANK OF CANADA /FI/, JANE STREET GROUP, LLC, Nuveen Asset Management, LLC, and VANGUARD GROUP INC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
34
Q2 2023 holders
66
Holder diff
32
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.